AML cells, but not normal hematopoietic stem cells (HSCs), have been shown to constitutively express IDO1 (243) which in turn causes an increase in circulating CD4 + CD25 + FOXP3 + t cells in AML patients. Here, IDO1 is linked to acute myeloid leukemia.